Clinical trials
Completed Overweight trials in Russia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 5 |
| S.LAB (SOLOWAYS) | 3 |
| Eli Lilly and Company | 2 |
| Eurasian Association of Therapists | 2 |
| National Research Center for Preventive Medicine | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Overweight | 14 |
| Obesity | 13 |
| Nutrition Disorders | 3 |
| COVID-19 | 2 |
| Diabetes Mellitus | 2 |
| Hypertension | 2 |
| Pulmonary Disease, Chronic Obstructive | 2 |
| Weight Loss | 2 |
| Anemia | 1 |
| Arrhythmias, Cardiac | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.